ロード中...
HDAC inhibitors in kidney development and disease
The discovery that histone deacetylase inhibitors (HDACis) can attenuate acute kidney injury (AKI)-mediated damage and reduce fibrosis in kidney disease models has opened the possibility of utilizing HDACis as therapeutics for renal injury. Studies to date have made it abundantly clear that HDACi tr...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3751322/ https://ncbi.nlm.nih.gov/pubmed/23052657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-012-2320-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|